Annual CFO
$548.81 M
-$185.51 M-25.26%
31 March 2024
Summary:
Dr Reddys Laboratories Limited annual cash flow from operations is currently $548.81 million, with the most recent change of -$185.51 million (-25.26%) on 31 March 2024. During the last 3 years, it has risen by +$68.76 million (+14.32%). RDY annual CFO is now -25.26% below its all-time high of $734.33 million, reached on 31 March 2023.RDY Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
$110.78 M
+$8.94 M+8.78%
01 September 2024
Summary:
Dr Reddys Laboratories Limited quarterly cash flow from operations is currently $110.78 million, with the most recent change of +$8.94 million (+8.78%) on 01 September 2024. Over the past year, it has dropped by -$105.14 million (-48.69%). RDY quarterly CFO is now -60.09% below its all-time high of $277.57 million, reached on 31 December 2022.RDY Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
$408.57 M
-$105.14 M-20.47%
01 September 2024
Summary:
Dr Reddys Laboratories Limited TTM cash flow from operations is currently $408.57 million, with the most recent change of -$105.14 million (-20.47%) on 01 September 2024. Over the past year, it has dropped by -$478.86 million (-53.96%). RDY TTM CFO is now -53.96% below its all-time high of $887.43 million, reached on 30 September 2023.RDY TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RDY Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -25.3% | -48.7% | -54.0% |
| 3 y3 years | +14.3% | +60.2% | +76.2% |
| 5 y5 years | +33.8% | -21.8% | -33.2% |
RDY Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -25.3% | +45.5% | -60.1% | +103.5% | -54.0% | +76.2% |
| 5 y | 5 years | -25.3% | +45.5% | -60.1% | +336.9% | -54.0% | +76.2% |
| alltime | all time | -25.3% | +3981.1% | -60.1% | +247.9% | -54.0% | +4104.3% |
Dr Reddys Laboratories Limited Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $110.78 M(+8.8%) | $408.57 M(-20.5%) |
| June 2024 | - | $101.84 M(-28.0%) | $513.72 M(-6.4%) |
| Mar 2024 | $548.81 M(-25.3%) | $141.52 M(+160.0%) | $548.81 M(-17.4%) |
| Dec 2023 | - | $54.44 M(-74.8%) | $664.30 M(-25.1%) |
| Sept 2023 | - | $215.92 M(+57.7%) | $887.43 M(+13.0%) |
| June 2023 | - | $136.94 M(-46.7%) | $785.00 M(+6.9%) |
| Mar 2023 | $734.33 M(+94.6%) | $257.01 M(-7.4%) | $734.33 M(+22.1%) |
| Dec 2022 | - | $277.57 M(+144.6%) | $601.32 M(+8.4%) |
| Sept 2022 | - | $113.49 M(+31.6%) | $554.70 M(+8.7%) |
| June 2022 | - | $86.26 M(-30.4%) | $510.34 M(+35.3%) |
| Mar 2022 | $377.32 M(-21.4%) | $124.00 M(-46.3%) | $377.32 M(-6.4%) |
| Dec 2021 | - | $230.94 M(+234.1%) | $402.96 M(+73.8%) |
| Sept 2021 | - | $69.13 M(-247.9%) | $231.87 M(-20.1%) |
| June 2021 | - | -$46.75 M(-131.2%) | $290.06 M(-39.6%) |
| Mar 2021 | $480.05 M(+14.2%) | $149.64 M(+150.0%) | $480.05 M(+30.5%) |
| Dec 2020 | - | $59.85 M(-53.0%) | $367.81 M(-9.9%) |
| Sept 2020 | - | $127.32 M(-11.1%) | $408.06 M(-3.4%) |
| June 2020 | - | $143.24 M(+283.0%) | $422.33 M(+0.5%) |
| Mar 2020 | $420.21 M(+2.4%) | $37.40 M(-62.6%) | $420.21 M(-13.9%) |
| Dec 2019 | - | $100.10 M(-29.3%) | $488.31 M(-20.2%) |
| Sept 2019 | - | $141.59 M(+0.3%) | $611.71 M(-2.3%) |
| June 2019 | - | $141.13 M(+33.8%) | $626.37 M(+52.7%) |
| Mar 2019 | $410.33 M(+46.7%) | $105.50 M(-52.8%) | $410.33 M(+3.8%) |
| Dec 2018 | - | $223.50 M(+43.0%) | $395.16 M(+37.5%) |
| Sept 2018 | - | $156.25 M(-308.6%) | $287.43 M(+22.1%) |
| June 2018 | - | -$74.92 M(-182.9%) | $235.41 M(-15.8%) |
| Mar 2018 | $279.65 M(-12.8%) | $90.33 M(-22.0%) | $279.65 M(-11.9%) |
| Dec 2017 | - | $115.77 M(+11.1%) | $317.32 M(+14.0%) |
| Sept 2017 | - | $104.23 M(-439.7%) | $278.39 M(+29.7%) |
| June 2017 | - | -$30.68 M(-124.0%) | $214.60 M(-33.1%) |
| Mar 2017 | $320.81 M(-49.1%) | $128.01 M(+66.6%) | $320.81 M(-5.1%) |
| Dec 2016 | - | $76.84 M(+90.0%) | $338.06 M(-22.9%) |
| Sept 2016 | - | $40.44 M(-46.5%) | $438.55 M(-23.1%) |
| June 2016 | - | $75.54 M(-48.0%) | $570.31 M(-9.6%) |
| Mar 2016 | $630.53 M(+54.0%) | $145.25 M(-18.1%) | $630.53 M(-3.9%) |
| Dec 2015 | - | $177.33 M(+3.0%) | $656.35 M(+15.4%) |
| Sept 2015 | - | $172.20 M(+26.8%) | $568.80 M(+21.3%) |
| June 2015 | - | $135.75 M(-20.6%) | $469.07 M(+14.5%) |
| Mar 2015 | $409.52 M(+26.8%) | $171.07 M(+90.5%) | $409.52 M(+8.3%) |
| Dec 2014 | - | $89.78 M(+23.9%) | $378.05 M(-2.0%) |
| Sept 2014 | - | $72.47 M(-4.9%) | $385.94 M(+21.1%) |
| June 2014 | - | $76.20 M(-45.4%) | $318.59 M(-1.4%) |
| Mar 2014 | $323.01 M(+31.8%) | $139.59 M(+42.9%) | $323.01 M(+40.4%) |
| Dec 2013 | - | $97.67 M(+1804.6%) | $230.14 M(+15.0%) |
| Sept 2013 | - | $5.13 M(-93.6%) | $200.06 M(-21.1%) |
| June 2013 | - | $80.62 M(+72.5%) | $253.54 M(+3.5%) |
| Mar 2013 | $245.02 M | $46.73 M(-30.9%) | $245.02 M(-30.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2012 | - | $67.59 M(+15.3%) | $353.19 M(-6.1%) |
| Sept 2012 | - | $58.60 M(-18.7%) | $376.15 M(+8.9%) |
| June 2012 | - | $72.10 M(-53.5%) | $345.37 M(+2.0%) |
| Mar 2012 | $338.46 M(+92.4%) | $154.90 M(+71.1%) | $338.46 M(+70.0%) |
| Dec 2011 | - | $90.55 M(+225.4%) | $199.06 M(-0.4%) |
| Sept 2011 | - | $27.83 M(-57.3%) | $199.88 M(-10.1%) |
| June 2011 | - | $65.19 M(+320.5%) | $222.29 M(+26.4%) |
| Mar 2011 | $175.92 M(-37.0%) | $15.50 M(-83.0%) | $175.92 M(-9.5%) |
| Dec 2010 | - | $91.37 M(+81.9%) | $194.36 M(+20.4%) |
| Sept 2010 | - | $50.24 M(+167.0%) | $161.40 M(-22.9%) |
| June 2010 | - | $18.82 M(-44.6%) | $209.44 M(-25.0%) |
| Mar 2010 | $279.24 M(+184.5%) | $33.94 M(-41.9%) | $279.24 M(-21.9%) |
| Dec 2009 | - | $58.41 M(-40.6%) | $357.39 M(+22.4%) |
| Sept 2009 | - | $98.27 M(+10.9%) | $292.00 M(+77.3%) |
| June 2009 | - | $88.62 M(-20.9%) | $164.70 M(+67.8%) |
| Mar 2009 | $98.16 M(-39.7%) | $112.09 M(-1707.0%) | $98.16 M(+61.5%) |
| Dec 2008 | - | -$6.98 M(-76.0%) | $60.78 M(-39.5%) |
| Sept 2008 | - | -$29.03 M(-231.5%) | $100.41 M(-22.4%) |
| June 2008 | - | $22.08 M(-70.5%) | $129.47 M(-20.5%) |
| Mar 2008 | $162.90 M(-38.0%) | $74.71 M(+128.7%) | $162.90 M(-20.9%) |
| Dec 2007 | - | $32.66 M(>+9900.0%) | $206.05 M(-20.2%) |
| Sept 2007 | - | $19.90 K(-100.0%) | $258.20 M(-22.9%) |
| June 2007 | - | $55.51 M(-52.9%) | $334.86 M(+27.5%) |
| Mar 2007 | $262.61 M(+603.4%) | $117.86 M(+39.0%) | $262.61 M(+77.2%) |
| Dec 2006 | - | $84.81 M(+10.6%) | $148.23 M(+80.3%) |
| Sept 2006 | - | $76.68 M(-558.1%) | $82.19 M(+415.4%) |
| June 2006 | - | -$16.74 M(-580.7%) | $15.95 M(-57.3%) |
| Mar 2006 | $37.33 M(-27.1%) | $3.48 M(-81.4%) | $37.33 M(-48.4%) |
| Dec 2005 | - | $18.77 M(+79.9%) | $72.38 M(+27.0%) |
| Sept 2005 | - | $10.44 M(+124.6%) | $56.97 M(+10.4%) |
| June 2005 | - | $4.65 M(-87.9%) | $51.61 M(+0.8%) |
| Mar 2005 | $51.18 M(-41.4%) | $38.53 M(+1046.0%) | $51.18 M(+40.2%) |
| Dec 2004 | - | $3.36 M(-33.7%) | $36.51 M(-32.8%) |
| Sept 2004 | - | $5.07 M(+20.1%) | $54.34 M(-26.4%) |
| June 2004 | - | $4.22 M(-82.3%) | $73.80 M(-15.4%) |
| Mar 2004 | $87.27 M(-2.9%) | $23.85 M(+12.5%) | $87.27 M(+7.9%) |
| Dec 2003 | - | $21.20 M(-13.6%) | $80.86 M(+4.3%) |
| Sept 2003 | - | $24.53 M(+38.7%) | $77.52 M(+10.9%) |
| June 2003 | - | $17.69 M(+1.4%) | $69.88 M(-22.3%) |
| Mar 2003 | $89.91 M(-7.6%) | $17.45 M(-2.3%) | $89.91 M(-18.4%) |
| Dec 2002 | - | $17.86 M(+5.8%) | $110.16 M(-17.0%) |
| Sept 2002 | - | $16.89 M(-55.2%) | $132.68 M(+5.9%) |
| June 2002 | - | $37.72 M(+0.1%) | $125.31 M(+28.8%) |
| Mar 2002 | $97.30 M(+623.6%) | $37.69 M(-6.7%) | $97.30 M(+63.2%) |
| Dec 2001 | - | $40.38 M(+324.5%) | $59.61 M(+210.0%) |
| Sept 2001 | - | $9.51 M(-2.1%) | $19.23 M(+97.9%) |
| June 2001 | - | $9.72 M | $9.72 M |
| Mar 2001 | $13.45 M | - | - |
FAQ
- What is Dr Reddys Laboratories Limited annual cash flow from operations?
- What is the all time high annual CFO for Dr Reddys Laboratories Limited?
- What is Dr Reddys Laboratories Limited annual CFO year-on-year change?
- What is Dr Reddys Laboratories Limited quarterly cash flow from operations?
- What is the all time high quarterly CFO for Dr Reddys Laboratories Limited?
- What is Dr Reddys Laboratories Limited quarterly CFO year-on-year change?
- What is Dr Reddys Laboratories Limited TTM cash flow from operations?
- What is the all time high TTM CFO for Dr Reddys Laboratories Limited?
- What is Dr Reddys Laboratories Limited TTM CFO year-on-year change?
What is Dr Reddys Laboratories Limited annual cash flow from operations?
The current annual CFO of RDY is $548.81 M
What is the all time high annual CFO for Dr Reddys Laboratories Limited?
Dr Reddys Laboratories Limited all-time high annual cash flow from operations is $734.33 M
What is Dr Reddys Laboratories Limited annual CFO year-on-year change?
Over the past year, RDY annual cash flow from operations has changed by -$185.51 M (-25.26%)
What is Dr Reddys Laboratories Limited quarterly cash flow from operations?
The current quarterly CFO of RDY is $110.78 M
What is the all time high quarterly CFO for Dr Reddys Laboratories Limited?
Dr Reddys Laboratories Limited all-time high quarterly cash flow from operations is $277.57 M
What is Dr Reddys Laboratories Limited quarterly CFO year-on-year change?
Over the past year, RDY quarterly cash flow from operations has changed by -$105.14 M (-48.69%)
What is Dr Reddys Laboratories Limited TTM cash flow from operations?
The current TTM CFO of RDY is $408.57 M
What is the all time high TTM CFO for Dr Reddys Laboratories Limited?
Dr Reddys Laboratories Limited all-time high TTM cash flow from operations is $887.43 M
What is Dr Reddys Laboratories Limited TTM CFO year-on-year change?
Over the past year, RDY TTM cash flow from operations has changed by -$478.86 M (-53.96%)